PATENT CLAIM ANALYSIS

Application Number: 15746970
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-11
Patent Classification: ["435", "173400"]

Abstract:
The present invention relates to mutated factor (FX) polypeptides and uses thereof for the treatment of haemophilia. In particular, the present invention relates to a mutated factor X (FX) polypeptide which comprises a heavy chain wherein at least one amino acid residue at position 401 or 408 is mutated.

Claim (Index 12):
A method of treating haemophilia in a subject in need thereof comprising administering to the subject with a therapeutically effective amount of the mutated factor X (FX) polypeptide of  claim 1  or a nucleic acid encoding the mutated factor X (FX) polypeptide.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 86.0
- Lexical Diversity: 1.33333
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15542218', '13139367', '13909323', '14244840', '13732465']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5436482482930991
- 35 USC 102 Novelty (BERT): 0.5672029070891301
- Combined Prediction Score: 0.5460037141727022
- Mean Citation Score: 322.317072
- Max Citation Score: 478.6959
- Similarity Product: 374.3734366722822

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test